talipexole
Sign in to saveAlso known as B-HT920, BHT920
Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe.
Wikidata facts
- Mass
- 209.098668
Show 3 more facts
- Commons category
- Talipexole
- chemical formula
- C₁₀H₁₅N₃S
- canonical SMILES
- C=CCN1CCC2=C(CC1)SC(=N2)N
Sources (2)
via Wikidata · CC0
~1 min read
Article
3 sectionsContents
- Synthesis
- See also
- References
Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe.
Talipexole is a dopamine D2 receptor agonist and interacts with both pre- and post-synaptic receptors. It also is an α2-adrenergic agonist.
Connections
propranolol
Entity
atenolol
Entity
adrenergic receptor
Entity
labetalol
Entity
levobunolol
Entity
dopamine agonist
Entity
exaprolol
Entity
medication
Entity
nervous system
Entity
Wayback Machine
Entity
digital object identifier
Entity
chemical formula
Entity
caffeine
Entity
epinephrine
Entity
dopamine
Entity
lysergic acid diethylamide
Entity
molar mass
Entity
(RS)-ketamine
Entity
Q180686
Entity
L-tyrosine
Entity
Categories
AllylaminesAlpha-1 blockersAlpha2-adrenergic agonistsAzepanesChemical articles with multiple CAS registry numbersChemical pages without DrugBank identifierChemicals using indexlabelsD2 receptor agonistsDopamine agonistsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs not assigned an ATC codeDrugs with non-standard legal statusMultiple chemicals in Infobox drugThiazoles